Belhadj K - Search Results

1

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

Fitoussi O, Belhadj K, Mounier N, Parrens M, Tilly H, Salles G, Feugier P, Ferme C, Ysebaert L, Gabarre J, Herbrecht R, Janvier M, Van Den Neste E, Morschhauser F, Casasnovas O, Ghesquieres H, Anglaret B, Brechignac S, Haioun C, Gisselbrecht C. Fitoussi O, et al. Among authors: belhadj k. Haematologica. 2011 Aug;96(8):1136-43. doi: 10.3324/haematol.2010.038109. Epub 2011 May 5. Haematologica. 2011. PMID: 21546499 Free PMC article. Clinical Trial.

2

Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.

Andreozzi F, Dragani M, Quivoron C, Le Bras F, Assi T, Danu A, Belhadj K, Lazarovici J, Cotteret S, Bernard OA, Ribrag V, Michot JM. Andreozzi F, et al. Among authors: belhadj k. Cancers (Basel). 2023 Feb 28;15(5):1508. doi: 10.3390/cancers15051508. Cancers (Basel). 2023. PMID: 36900299 Free PMC article.

3

Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.

Decaudin D, Lepage E, Brousse N, Brice P, Harousseau JL, Belhadj K, Tilly H, Michaux L, Chèze S, Coiffier B, Solal-Céligny P. Decaudin D, et al. Among authors: belhadj k. J Clin Oncol. 1999 Aug;17(8):2499-505. doi: 10.1200/JCO.1999.17.8.2499. J Clin Oncol. 1999. PMID: 10561315

4

Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients.

Haioun C, Mounier N, Quesnel B, Morel P, Rieux C, Beaujean F, Marolleau JP, Belhadj K, Simon D, Gaulard PH, Lepage E, Gisselbrecht CH, Reyes F. Haioun C, et al. Among authors: belhadj k. Ann Oncol. 2001 Dec;12(12):1749-55. doi: 10.1023/a:1013578523579. Ann Oncol. 2001. PMID: 11843254 Free article.

5

T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis.

Bouabdallah R, Mounier N, Guettier C, Molina T, Ribrag V, Thieblemont C, Sonet A, Delmer A, Belhadj K, Gaulard P, Gisselbrecht C, Xerri L. Bouabdallah R, et al. Among authors: belhadj k. J Clin Oncol. 2003 Apr 1;21(7):1271-7. doi: 10.1200/JCO.2003.06.046. J Clin Oncol. 2003. PMID: 12663714

6

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia.

Tournilhac O, Cazin B, Leprètre S, Diviné M, Maloum K, Delmer A, Grosbois B, Feugier P, Maloisel F, Villard F, Villemagne B, Bastit D, Belhadj K, Azar N, Michallet M, Manhès G, Travade P. Tournilhac O, et al. Among authors: belhadj k. Blood. 2004 Jan 1;103(1):363-5. doi: 10.1182/blood-2003-05-1449. Epub 2003 Sep 11. Blood. 2004. PMID: 12969985 Free article.

7

Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.

Coiffier B, Mounier N, Bologna S, Fermé C, Tilly H, Sonet A, Christian B, Casasnovas O, Jourdan E, Belhadj K, Herbrecht R; Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma. Coiffier B, et al. Among authors: belhadj k. J Clin Oncol. 2003 Dec 1;21(23):4402-6. doi: 10.1200/JCO.2003.04.115. Epub 2003 Oct 27. J Clin Oncol. 2003. PMID: 14581437 Clinical Trial.

8

Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.

Belhadj K, Delfau-Larue MH, Elgnaoui T, Beaujean F, Beaumont JL, Pautas C, Gaillard I, Kirova Y, Allain A, Gaulard P, Farcet JP, Reyes F, Haioun C. Belhadj K, et al. Ann Oncol. 2004 Mar;15(3):504-10. doi: 10.1093/annonc/mdh090. Ann Oncol. 2004. PMID: 14998857 Free article.

9

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L, Lepage E, Reyes F, Meignan M. Haioun C, et al. Among authors: belhadj k. Blood. 2005 Aug 15;106(4):1376-81. doi: 10.1182/blood-2005-01-0272. Epub 2005 Apr 28. Blood. 2005. PMID: 15860666 Free article. Clinical Trial.

10

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Bossard C, Belhadj K, Reyes F, Martin-Garcia N, Berger F, Kummer JA, Brière J, Baglin AC, Cheze S, Bosq J, Ribrag V, Gisselbrecht C, Mounier N, Gaulard P. Bossard C, et al. Among authors: belhadj k. Blood. 2007 Mar 1;109(5):2183-9. doi: 10.1182/blood-2006-07-033142. Epub 2006 Oct 31. Blood. 2007. PMID: 17077322 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters